• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CTI BioPharma Corp. - Common Stock (NQ: CTIC )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 23, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CTI BioPharma Corp. - Common Stock

    < Previous 1 2 3 4 Next >
    Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
    Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer. 
    Via Investor's Business Daily
    CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    CTI BioPharma Corp. (NASDAQ: CTIC) Climbs to New 52-Week High
    Via Investor Brand Network
    Top 5 Health Care Stocks That Should Keep You Up At Night
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
    Via Benzinga
    The Latest Analyst Ratings for CTI BioPharma
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
    Via Benzinga
    CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Dow Falls 90 Points; Mesa Air Group Shares Plummet
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1% points on Wednesday. The Dow traded down 0.27% to 33,471.60 while the NASDAQ rose 1.01% to 12,302.61. The... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq, S&P 500 Higher As Bond Yields Retreat
    Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. 
    Via Talk Markets
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
    Via Benzinga
    Crude Oil Down 1%; Microvast Holdings Shares Spike Higher
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded down 0.28% to 33,469.12 while the NASDAQ rose 0.75% to 12,270.95. The S&P... 
    Via Benzinga
    Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    CTI BioPharma Corp. (NASDAQ: CTIC) Near Top of Volume Charts in Wednesday Trading
    Via Investor Brand Network
    Why Shares of CTI BioPharma Are Soaring Wednesday
    A buyout offer from Swedish Orphan Biovitrum drove up the stock's price. 
    Via The Motley Fool
    Nasdaq Surges Over 1%; US Inflation Falls In April
    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Wednesday. 
    Via Benzinga
    SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
    Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is SeaStar Medical (ICU) Stock Down 32% Today?
    SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA. 
    Via InvestorPlace
    Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
    Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. 
    Via Benzinga
    CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Why Is Babylon (BBLN) Stock Down 57% Today?
    Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. 
    Via InvestorPlace
    Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
    CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi. 
    Via InvestorPlace
    European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
    Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of  
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! 
    Via InvestorPlace
    What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
    Incyte Corporation (NASDAQ: INCY) will report Q1 FY23 results on May 2.  Investor focus remains on the Opzelura launch, which has faced some hiccups over the first 18 months of launch and began to gain... 
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.